<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Chemotherapeutic Agents: Antibacterials</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="pharmacology-introduction.html" class="nav-button">
                        <span class="nav-icon">‚Üê</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 18%;"></div> <!-- Set percentage dynamically -->
                        </div>
                       <span class="progress-text">Lecture 2 of 11</span> <!-- Update text -->
                    </div>
                    <a href="pharmacology-chemotherapeutic-agents-antimycobacterials-antifungals-antivirals.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Chemotherapeutic Agents: Antibacterials</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">

                <!-- START: drug-effects-continued -->
                <section id="drug-effects-continued" class="content-section" aria-labelledby="section-heading-drug-effects-continued">
                    <h2 id="section-heading-drug-effects-continued" class="section-heading">
                         <span class="heading-icon">üåü</span>
                        <span class="heading-text">Drug Effects (Continued)</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Beneficial Responses</h3>
                        <figure>
                            <img src="../assets/images/2025_06_04_f97241427b76be89d93fg-01-1.jpg" alt="Diagram illustrating Therapeutic Effect as a beneficial response to a drug. The image shows the text 'Therapeutic Effect'." class="content-image">
                            <figcaption>The action for which the drug is prescribed</figcaption>
                        </figure>
                        <p>Confined to a specific part of the body</p>
                        <ul>
                            <li><strong>Therapeutic Effect:</strong> The action for which the drug is prescribed</li>
                            <li><strong>Local Effect:</strong> Confined to a specific part of the body</li>
                            <li><strong>Systemic Effect:</strong> Generalized, all-inclusive effect on entire body</li>
                        </ul>

                        <h3 class="subsection-heading">Considerations for Drug Choice</h3>
                        <p>When choosing a drug for a patient, a healthcare practitioner considers:</p>
                        <p><strong>Indications:</strong> The diseases, symptoms, and conditions for which the drug is known to be of benefit.</p>
                        <p><strong>Contraindications:</strong> The diseases, symptoms, and conditions for which the drug will not be beneficial and may do harm.</p>

                        <h3 class="subsection-heading">Side Effects</h3>
                        <p>Secondary responses to a drug other than the primary therapeutic effect for which the drug was intended</p>
                        <ul>
                            <li>Allergic responses</li>
                            <li>Drug dependence, addiction, abuse, and tolerance</li>
                        </ul>
                    </div>
                </section>
                <!-- END: drug-effects-continued -->

                <!-- START: common-drug-relationships -->
                <section id="common-drug-relationships" class="content-section" aria-labelledby="section-heading-drug-relationships">
                    <h2 id="section-heading-drug-relationships" class="section-heading">
                         <span class="heading-icon">ü§ù</span>
                        <span class="heading-text">Common Drug Relationships</span>
                    </h2>
                    <div class="content-card">
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Common Drug Relationships</caption>
                                <thead>
                                    <tr>
                                        <th>Term</th>
                                        <th>Description</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>Addition</strong></td>
                                        <td>The combined effect of two drugs. It is equal to the sum of the effects of each drug taken alone.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Antagonism</strong></td>
                                        <td>The action of one drug negates the action of a second drug.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Potentiation</strong></td>
                                        <td>An effect that occurs when a drug increases or prolongs the action of another drug, and the total effect is greater than the sum of the effects of each drug used alone.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Synergism</strong></td>
                                        <td>Joint action of drugs in which their combined effect is more intense or longer in duration than the sum of their individual effects.</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>
                <!-- END: common-drug-relationships -->

                <!-- START: rights-drug-administration -->
                <section id="rights-drug-administration" class="content-section" aria-labelledby="section-heading-rights-drug-admin">
                    <h2 id="section-heading-rights-drug-admin" class="section-heading">
                         <span class="heading-icon">üìú</span>
                        <span class="heading-text">"Rights" for Drug Administration</span>
                    </h2>
                    <div class="content-card">
                        <figure>
                            <img src="../assets/images/2025_06_04_f97241427b76be89d93fg-07-1.jpg" alt="Diagram illustrating the 'Rights' of Drug Administration: Right Drug, Right Time, Right Route." class="content-image">
                            <figcaption>Rights for Drug Administration: Right Drug, Right Time, Right Route.</figcaption>
                        </figure>
                    </div>
                </section>
                <!-- END: rights-drug-administration -->

                <!-- START: factors-influencing-drug-action -->
                <section id="factors-influencing-drug-action" class="content-section" aria-labelledby="section-heading-factors-drug-action">
                    <h2 id="section-heading-factors-drug-action" class="section-heading">
                         <span class="heading-icon">üåê</span>
                        <span class="heading-text">Factors that Influence Drug Action</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li><strong>Age:</strong> Pediatric patients and elderly patients may need a reduced dose because of smaller size or inability of liver to metabolize medication</li>
                            <li><strong>Disease:</strong> Specific diseases may hinder the pharmacokinetic process of some drugs</li>
                            <li><strong>Mental State, Genes, Gender</strong></li>
                        </ul>
                        <h3 class="subsection-heading">Considerations for Pediatric Patients</h3>
                        <ul>
                            <li>Wide variation between age and degree of organ-system development</li>
                            <li>Reevaluate all doses at regular intervals.</li>
                            <li>Be sure the dosage is appropriate for the child's age.</li>
                            <li>Always double-check all computations.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: factors-influencing-drug-action -->

                <!-- START: chemotherapeutic-agents-overview -->
                <section id="chemotherapeutic-agents-overview" class="content-section" aria-labelledby="section-heading-chemo-overview">
                    <h2 id="section-heading-chemo-overview" class="section-heading">
                         <span class="heading-icon">üíä</span>
                        <span class="heading-text">A. CHEMOTHERAPEUTIC AGENTS</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Antibacterial agents</li>
                            <li>Antifungal agents</li>
                            <li>Antiviral agents</li>
                            <li>Antihelminthic agents</li>
                            <li>Antiprotozoa agents</li>
                            <li>Anticancer agents</li>
                        </ul>
                        <p>B. SYSTEMIC PHARMACOLOGY: DRUGS ACTING ON:-</p>
                        <ul>
                            <li>Cardiovascular system</li>
                            <li>Respiratory system</li>
                            <li>Gastro-intestinal system</li>
                            <li>Central nervous system</li>
                        </ul>
                    </div>
                </section>
                <!-- END: chemotherapeutic-agents-overview -->

                <!-- START: chemotherapeutic-agents-definition -->
                <section id="chemotherapeutic-agents-definition" class="content-section" aria-labelledby="section-heading-chemo-definition">
                    <h2 id="section-heading-chemo-definition" class="section-heading">
                         <span class="heading-icon">üî¨</span>
                        <span class="heading-text">CHEMOTHERAPEUTIC AGENTS</span>
                    </h2>
                    <div class="content-card">
                        <p><strong>Definition:</strong> Substances/chemicals that kill or inhibit the growth of infective agents or cancerous cells in the body</p>
                        <p><strong>Antibiotics (Antibacterial agents):</strong> substances produced by microorganisms that in very dilute concentration kill or inhibit other microorganisms</p>
                        <p>The goal of this agents is to be toxic (kill or sufficiently inhibit growth of) to microorganism or cancerous tissue while being harmless (minimally) to the host or non-cancerous tissue</p>
                    </div>
                </section>
                <!-- END: chemotherapeutic-agents-definition -->

                <!-- START: terminologies-chemo -->
                <section id="terminologies-chemo" class="content-section" aria-labelledby="section-heading-terminologies-chemo">
                    <h2 id="section-heading-terminologies-chemo" class="section-heading">
                         <span class="heading-icon">üìñ</span>
                        <span class="heading-text">Terminologies</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">1. Bactericidal vs bacteriostatic</h3>
                        <p><strong>a) Bacteriostatic</strong> - agents that inhibit the growth (replication) of the infective agent.</p>
                        <ul>
                            <li>The body requires an effective immune defense.</li>
                        </ul>
                        <p><strong>b) Bacteriocidal</strong> - agents that kills the sensitive infective agent. The body does not requires an effective immune system.</p>
                        <ul>
                            <li>These agents are indicated when host immune defense is impaired, in neutropenic patients (e.g. cancer) or in life threatening situations endocarditis, meningitis.</li>
                        </ul>
                        <p>Bacteriocidal drugs exhibit either:-</p>
                        <ul>
                            <li><strong>Concentration dependent killing</strong> - rate and extent of cidal activity increases with conc. of drug e.g. aminoglycosides, quinolones</li>
                            <li><strong>Time-dependent killing</strong> - rate and extent of killing is maximal above the minimum bactericidal conc. and does not increase beyond this.</li>
                        </ul>
                        <h3 class="subsection-heading">2. Post-antibiotic effect</h3>
                        <p>Persistent microbial suppression even after the plasma concentration of a drug falls below the minimum inhibitory concentration. e.g. aminoglycosides, quinolones.</p>
                        <h3 class="subsection-heading">3. Spectrum of a chemotherapeutic agent</h3>
                        <ul>
                            <li><strong>Narrow</strong> - sensitivity limited to a small group of organisms</li>
                            <li><strong>Broad</strong> - many groups of organism sensitive to the effect of that agent (often inclusive of both gram negative and positive. A common side effect is superinfection.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: terminologies-chemo -->

                <!-- START: classification-antibacterials -->
                <section id="classification-antibacterials" class="content-section" aria-labelledby="section-heading-classification-antibacterials">
                    <h2 id="section-heading-classification-antibacterials" class="section-heading">
                        <span class="heading-icon">üóÇÔ∏è</span>
                        <span class="heading-text">Classification of ANTIBACTERIALS...</span>
                    </h2>
                    <div class="content-card">
                        <ol>
                            <li><strong>Inhibitors of cell wall synthesis</strong>
                                <ul>
                                    <li>a). Beta-lactams (penicillins and cephalosporins)</li>
                                    <li>b). Vancomycin</li>
                                    <li>c). Others: teicoplanin, Bacitracin, Cycloserine, Fosfomycin</li>
                                </ul>
                            </li>
                            <li><strong>Protein synthesis inhibitors</strong>
                                <ul>
                                    <li>Tetracylines</li>
                                    <li>Aminoglycosides</li>
                                    <li>Chloramphenicol</li>
                                    <li>Macrolides</li>
                                    <li>Lincosamides</li>
                                    <li>Spectinomycin</li>
                                </ul>
                            </li>
                            <li><strong>Antifolates</strong>
                                <ul>
                                    <li>Sulphonamides</li>
                                    <li>Trimethoprim</li>
                                </ul>
                            </li>
                            <li><strong>Inhibitors of nucleic acid synthesis</strong>
                                <ul>
                                    <li>Quinolones</li>
                                </ul>
                            </li>
                            <li><strong>Antimycobacterials</strong>
                                <ul>
                                    <li>a). Drugs for TB
                                        <ul>
                                            <li>Isoniazid</li>
                                            <li>Rifampicin</li>
                                            <li>Pyrazinamide</li>
                                            <li>Ethambutol</li>
                                            <li>Streptomycin</li>
                                            <li>others: Ethionamide, Cycloserine</li>
                                        </ul>
                                    </li>
                                    <li>b). Drugs for leprosy
                                        <ul>
                                            <li>Clofazimine</li>
                                            <li>Dapsone</li>
                                            <li>Rifampicin</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                        </ol>
                    </div>
                </section>
                <!-- END: classification-antibacterials -->

                <!-- START: penicillin-history -->
                <section id="penicillin-history" class="content-section" aria-labelledby="section-heading-penicillin-history">
                    <h2 id="section-heading-penicillin-history" class="section-heading">
                        <span class="heading-icon">üï∞Ô∏è</span>
                        <span class="heading-text">Thanks to PENICILLIN He Will Come Home! Second World War</span>
                    </h2>
                    <div class="content-card">
                        <p>The first antibiotic, penicillin, was discovered in 1929 by Sir Alexander Fleming, who observed inhibition of staphylococci on an agar plate contaminated by a Penicillium mold.</p>
                        <p>He named the active substance penicillin but was unable to isolate it.</p>
                        <figure>
                            <img src="../assets/images/2025_06_04_f97241427b76be89d93fg-18-1.jpg" alt="World War II poster stating 'Thanks to PENICILLIN He Will Come Home!' depicting a soldier returning home." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: penicillin-history -->

                <!-- START: cell-wall-synthesis-inhibitors -->
                <section id="cell-wall-synthesis-inhibitors" class="content-section" aria-labelledby="section-heading-cell-wall-inhibitors">
                    <h2 id="section-heading-cell-wall-inhibitors" class="section-heading">
                        <span class="heading-icon">üß±</span>
                        <span class="heading-text">1. Inhibitors of cell wall synthesis</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">a). $\beta$-LACTAM ANTIBACTERIALS</h3>
                        <p><strong>Mechanism of action:</strong> inhibit bacterial cell wall synthesis.</p>
                        <ul>
                            <li>Active only in organisms whose cell wall is formed of peptidoglycan</li>
                            <li>Require actively dividing cells</li>
                        </ul>

                        <h4 class="subsubsection-heading">Classes of beta lactams</h4>
                        <ul>
                            <li>Penicillins</li>
                            <li>Carbapenems</li>
                            <li>Cephalosporins</li>
                            <li>Monobactams</li>
                        </ul>

                        <h4 class="subsubsection-heading">Beta lactam ring</h4>
                        <pre class="code-block"><code class="language-smiles">[R]C(=O)NC1C(=O)N2[C@@H]1C(C)(C)S[C@H]2C(=O)O</code></pre>
                        <pre class="code-block"><code class="language-smiles">[Z]C(=O)NC1C(=O)N2C(C(=O)O)C([R])CS[C@H]12</code></pre>
                        <ul>
                            <li>Beta Lactam ring-a cyclic 4atom structure of several antibiotics.</li>
                            <li>$\beta$-lactamase - several enzymes(upto 100), that hydrolyze the beta lactam ring leading to loss of activity/resistance.</li>
                            <li>$\beta$-lactamase inhibitors - Clavulanic acid, sulbactam, tazobactam</li>
                            <li>These bind to and inactivate the $\beta$-lactamase enzyme</li>
                            <li>They are combined with some penicillins to increase the spectrum to cover $\beta$-lactamase producing organisms. E.g. Amoxicillin+clavulanic acid = Augmentin</li>
                        </ul>
                        <pre class="code-block"><code class="language-smiles">[R]C(=O)NC1C(=O)N2[C@@H](C(=O)O)SC(C)(C)[C@H]12</code></pre>
                        <pre class="code-block"><code class="language-smiles">[Z]C(=O)NC1C(=O)N2C(C(=O)O)C([R])CS[C@]12[Z]</code></pre>
                        <p>$\beta$-Lactam antibiotics (beta-lactam antibiotics) are a broad class of antibiotics, consisting of all antibiotic agents that contains a $\beta$-lactam nucleus in their molecular structures.</p>
                        <ul>
                            <li>This includes penicillin derivatives (penams), cephalosporins (cephems), monobactams, and carbapenems</li>
                            <li>Most $\beta$-lactam antibiotics work by inhibiting cell wall biosynthesis in the bacterial organism and are the most widely used group of antibiotics.</li>
                            <li>Bacteria often develop resistance to $\beta$-lactam antibiotics by synthesizing a $\beta$-lactamase, an enzyme that attacks the $\beta$-lactam ring.</li>
                        </ul>

                        <h4 class="subsubsection-heading">i). PENICILLINS in general P'kinetics</h4>
                        <p><strong>Adm:</strong> most of them administered parenteral e.g benzylpenicillin</p>
                        <p><strong>Distribution:</strong> Wide but with poor penetration into cells esp. CSF, eye. It can penetrate inflamed meninges</p>
                        <p><strong>Elimination:</strong> Short $t_{1/2}$ (<12hr) hence requires multiple dosing. Eliminated by Renal tubular secretion.</p>
                        <p><strong>S/E:</strong></p>
                        <ol>
                            <li>Hypersensitivity reactions - fever, itching, rashes, angioneurotic edema, anaphylactic shock.
                                <ul>
                                    <li>Have cross-sensitivity with cephalosporins</li>
                                </ul>
                            </li>
                            <li>GIT upset such as nausea, vomiting and diarrhoea.</li>
                            <li>Blood disorders - neutropenia, anemia</li>
                            <li>Hepatitis</li>
                            <li>Convulsions - with very high doses.</li>
                        </ol>

                        <h4 class="subsubsection-heading">Penicillins: Spectrum and uses</h4>
                        <h5 class="subsubsection-heading">1. Narrow spectrum; $\beta$-lactamase sensitive</h5>
                        <p>Examples: Benzylpenicillin (Pen G-Cristapen penicillin)</p>
                        <p><strong>Uses:</strong></p>
                        <ul>
                            <li>Streptococcal Pneumonia</li>
                            <li>Meningococcal meningitis</li>
                            <li>Anthrax</li>
                            <li>Gas gangrene</li>
                            <li>Tetanus</li>
                            <li>Diphtheria</li>
                        </ul>
                        <p>Benzathine penicillin - administered I.M, has a half life of > 14 days.</p>
                        <ul>
                            <li><strong>Uses:</strong> Rheumatic heart disease (dose of 1.2 MU monthly), syphilis</li>
                        </ul>
                        <p>Phenoxymethylpenicillin administered per oral.</p>
                        <ul>
                            <li><strong>Uses</strong> - Non-acute infections such as streptococcal pneumonia, streptococcal pharyngitis.</li>
                        </ul>
                        <p>Procaine penicillin (PPF) infrequently used.</p>

                        <h5 class="subsubsection-heading">2. Anti-staphyloccocal penicillins: Narrow spectrum, $\beta$-lactamase resistant.</h5>
                        <p>Examples: Oxacillin, cloxacillin, dicloxacillin, Flucloxacillin (administered per oral)</p>
                        <p>Methicillin, Nafcillin (administered parenterally).</p>
                        <p><strong>Uses:</strong> $\beta$-lactamase producing staphylococcal infections of bone, joint.</p>

                        <h5 class="subsubsection-heading">3. Extended spectrum: $\beta$-lactamase sensitive.</h5>
                        <p>Examples: ampicillin, amoxycillin)</p>

                        <h5 class="subsubsection-heading">4. Anti-pseudomonal penicillins, broad spectrum, $\beta$-lactamase sensitive, most administered parenteral</h5>
                        <p>E.g. Piperacillin, carbenicillin, tircacillin, azlocillin, mezlocillin</p>
                        <p>NB. Penicillins inactivate aminoglycosides if given in same syringe or IV infusion (but the two act synergistically).</p>

                        <h4 class="subsubsection-heading">ii). CEPHALOSPORINS</h4>
                        <p><strong>Mechanism of action:</strong> cell wall synthesis inhibitors</p>
                        <ul>
                            <li>they are more resistant to $\beta$-lactamases compared to penicillins</li>
                        </ul>
                        <p><strong>Adm:</strong> most are given parenterally due to poor GIT absorption.</p>
                        <p><strong>Distribution:</strong> Wide including - bone, joints, soft tissues, pleural, pericardial, placenta. $3^{\text{rd}}$ generation cross the meninges adequately.</p>
                        <p><strong>Elimination:</strong> Short half life (1-4hrs) hence require multiple dosing. Most eliminated by Renal excretion.</p>
                        <p><strong>S/E:</strong></p>
                        <ol>
                            <li>Hypersensitivity reactions - have a cross allergy with penicillins</li>
                            <li>Long-term use can lead to: thrombocytopenia, neutropenia, Reversible renal damage, Abnormal liver function</li>
                            <li>Opportunistic infections.</li>
                            <li>Cholelithiasis especially with ceftriaxone</li>
                            <li>Intolerance to alcohol - Disulfiram like reaction especially with cefamandole</li>
                        </ol>

                        <h4 class="subsubsection-heading">CEPHALOSPORINS (Generations and Uses)</h4>
                        <h5 class="subsubsection-heading">1st generation:</h5>
                        <p>E.g. cephalexin, cefazolin, cefadroxil, cephadrin</p>
                        <p><strong>Uses:</strong> bone infections, skin & soft tissue infections, uncomplicated UTIs.</p>
                        <h5 class="subsubsection-heading">$2^{\text{nd}}$ generation:</h5>
                        <p>E.g. cefaclor, cefuroxime, cefoxitin, cefamandole, cefotetan</p>
                        <p><strong>Uses:</strong></p>
                        <ul>
                            <li>Intra-abdominal sepsis (caused by anaerobes)</li>
                            <li>Pelvic inflammatory diseases</li>
                            <li>Bronchitis, pneumonia & otitis media</li>
                        </ul>
                        <h5 class="subsubsection-heading">$3^{\text{rd}}$ generation:</h5>
                        <p>E.g. Ceftriaxone, cefotaxime, ceftazidime, ceftizoxime, cefoperazone, cefixime</p>
                        <p><strong>Uses:</strong></p>
                        <ul>
                            <li>Pseudomonas infections</li>
                            <li>CNS infections- meningitis due to H. influenza in children</li>
                            <li>Gonorrhea</li>
                            <li>Bone infections</li>
                        </ul>
                        <h5 class="subsubsection-heading">$4^{\text{th}}$ generation:</h5>
                        <p>e.g cefepime</p>
                        <p><strong>Uses:</strong> Pneumonia due to multidrug resistant bacteria</p>
                        <p>Other beta-lactam antibiotics are carbapenems e.g imipenem;</p>

                        <h3 class="subsection-heading">b). VANCOMYCIN - bacteriocidal, $\beta$-lactamase resistant</h3>
                        <p><strong>Mechanism of action:</strong> inhibits bacterial cell wall synthesis.</p>
                        <p><strong>Administered:</strong> IV</p>
                        <p><strong>Distribution:</strong> widely distributed in the body (enters meninges if they are inflamed).</p>
                        <p><strong>Elimination:</strong> t1/2-8hrs, undergoes Renal excretion.</p>
                        <p><strong>S/E:</strong></p>
                        <ul>
                            <li>Ototoxic - causing tinnitus, deafness.</li>
                            <li>Nephrotoxic</li>
                            <li>Hypersensitivity reaction called maculopapular rash (REDMAN syndrome)</li>
                        </ul>
                        <p><strong>Uses:</strong></p>
                        <ul>
                            <li>Drug of Choice (DOC) in pseudomembraneous colitis caused by C.difficile</li>
                            <li>Methicillin Resistant Staphylococcal Aureus (MRSA) infections-</li>
                            <li>Streptococcal Endocarditis in combination with an aminoglycoside.</li>
                        </ul>
                        <p>Other inhibitors of cell wall synthesis include: Teicoplanin, fosfomycin, bacitracin, cycloserine.</p>
                    </div>
                </section>
                <!-- END: cell-wall-synthesis-inhibitors -->

                <!-- START: note-drug-classes -->
                <section id="note-drug-classes" class="content-section" aria-labelledby="section-heading-note-drug-classes">
                    <aside class="callout note" role="note">
                        <h4 class="callout-title"><span class="callout-icon">üìù</span> NOTE</h4>
                        <p>For every class of drugs:</p>
                        <ul>
                            <li>Mode of action</li>
                            <li>At least two examples</li>
                            <li>indications</li>
                            <li>Side effects</li>
                            <li>Nursing considerations</li>
                        </ul>
                    </aside>
                </section>
                <!-- END: note-drug-classes -->

                <!-- START: protein-synthesis-inhibitors -->
                <section id="protein-synthesis-inhibitors" class="content-section" aria-labelledby="section-heading-protein-synthesis-inhibitors">
                    <h2 id="section-heading-protein-synthesis-inhibitors" class="section-heading">
                        <span class="heading-icon">üß¨</span>
                        <span class="heading-text">2. Protein synthesis inhibitors</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">a). Tetracylines - Bacteriostatic</h3>
                        <p><strong>Mechanism:</strong> binds reversibly to the 30s ribosomal subunit to inhibit protein synthesis.</p>
                        <p>E.g. tetracycline, doxycycline, minocyline, chlortetracycline, oxytetracycline, demeclocycline</p>
                        <p><strong>Administered</strong> - per oral.</p>
                        <p><strong>Absorption</strong> - moderate, impaired in presence of metal ions & presence of food but doxyclycline and minocyline are completely absorbed.</p>
                        <p><strong>Distribution:</strong> wide including placenta, breastmilk but not meninges.</p>
                        <p><strong>S/E:</strong></p>
                        <ol>
                            <li>GIT irritation, Diarrhea, opportunistic infections</li>
                            <li>Deposited in growing bones, teeth to cause discoloration and bone deformity.</li>
                            <li>Photosensitivity (especially with Doxycycline)</li>
                            <li>Vit B deficiency -which can cause impaired mucosal degeneration</li>
                            <li>Fetal hepatotoxicity (in pregnant women)</li>
                            <li>Minocycline can cause vestibular disturbance (ataxia, vertigo)</li>
                        </ol>

                        <h4 class="subsubsection-heading">Tetracyclines: Contra-indications</h4>
                        <ul>
                            <li>Pregnant or breastfeeding women</li>
                            <li>Children below 8 years</li>
                            <li>Renally impairment(except doxycycline)</li>
                        </ul>
                        <h4 class="subsubsection-heading">Tetracyclines: Uses</h4>
                        <ul>
                            <li>Cholera</li>
                            <li>Mycoplasma pneumonia</li>
                            <li>Chlymydial infections</li>
                            <li>Lyme disease</li>
                            <li>Rickettsial diseases</li>
                            <li>Neisseria meningitidis - Minocyline only.</li>
                        </ul>

                        <h3 class="subsection-heading">b). AMINOGLYCOSIDES - bactericidal</h3>
                        <p>Highly polar compounds with poor penetration into tissues.</p>
                        <p><strong>Mechanism:</strong> binds 30s ribosomal subunit inhibiting protein synthesis.</p>
                        <p>E.g. Gentamycin, Streptomycin, Amikacin, Neomycin, tobramycin, netilmycin, sisomicin, kanamycin,</p>
                        <p><strong>Adm</strong> - Parenteral</p>
                        <p><strong>Distribution:</strong> distributed into most body fluids, but very poor penetration into CSF</p>
                        <p><strong>Elimination:</strong> Short $t_{1/2}$ (2-5hrs) - hence multiple dosing. Eliminated by the kidneys.</p>
                        <p><strong>S/E:</strong></p>
                        <ol>
                            <li>Ototoxicity (vestibular and auditory damage)- deafness, vertigo, ataxia, tinnitus.</li>
                            <li>Nephrotoxicity: reversible, related to dose and length of treatment. Increased risk with inefficient renal clearance e.g dehydration, impaired renal blood flow, preexisting renal disease, age.</li>
                            <li>Neuromuscular junction blockade - hence can cause aggravation of myasthenia gravis</li>
                        </ol>
                        <h4 class="subsubsection-heading">Aminoglycosides: Uses</h4>
                        <ul>
                            <li>Infection with enteric organisms in combination with an agent against anaerobes (metronidazole), pelvic and abdominal infections.</li>
                            <li>Bacterial endocarditis in combination with other drugs (penicillins)</li>
                            <li>Tuberculosis (streptomycin, is one of the regimens)</li>
                            <li>Plague</li>
                            <li>Brucellosis</li>
                            <li><img src="../assets/images/2025_06_04_7b41d6c443405c9900e5g-12-1.jpg" alt="Text snippet: bacterial infection of Skin, conjunctiva and external ear (topical)" style="display: inline; max-height: 1.5em; vertical-align: middle;"> bacterial infection of Skin, conjunctiva and external ear (topical)</li>
                        </ul>

                        <h3 class="subsection-heading">c). SPECTINOMYCIN</h3>
                        <p><strong>Mechanism:</strong> inhibits protein synthesis, binds to 30s subunit of bacterial ribosome.</p>
                        <ul>
                            <li>Has features very similar to aminoglycosides</li>
                        </ul>
                        <p><strong>Uses:</strong> limited to N.gonorrhea resistant or allergic to other preferred drugs.</p>

                        <h3 class="subsection-heading">d). CHLORAMPHENICOL</h3>
                        <p>Largely Bacteriostatic.</p>
                        <p><strong>Mechanism;</strong> binds reversibly to the 50s ribosomal subunit inhibiting protein synthesis.</p>
                        <p>NB. Macrolides and clindamycin bind to the same site and may interfere w/ each others activities</p>
                        <p><strong>Administration</strong> - oral (bitter taste masked by encapsulation), parenteral</p>
                        <p><strong>Absorption:</strong> rapid and complete</p>
                        <p><strong>Distribution:</strong> well into all tissues including brain. Undergoes some protein binding(30-50%)</p>
                        <p><strong>Elimination:</strong> undergoes liver metabolism</p>
                        <h4 class="subsubsection-heading">Drug interactions</h4>
                        <p>It inhibits hepatic enzymes, hence increasing the plasma levels of Warfarin, phenytoin, tolbutamide and chlorpropamide</p>
                        <h4 class="subsubsection-heading">Uses: only serious infections</h4>
                        <ol>
                            <li>Empiric (Before Dx) treatment of bacterial meningitis in conjunction with benzylpenicillin</li>
                            <li>Empiric treatment of brain abscess in conjunction with a penicillin</li>
                            <li>Salmonella infections- typhoid (2nd line drug)</li>
                            <li>Bacterial conjunctivitis (topical)</li>
                        </ol>
                        <h4 class="subsubsection-heading">CHLORAMPHENICOL S/E</h4>
                        <ol>
                            <li>Bone marrow depression causing pancytopenia (rare)</li>
                            <li>Grey baby syndrome- vomiting, diarrhea, poor blood flow (flaccid, cold, grey ashen)</li>
                            <li>Hypersensitivity reactions</li>
                            <li>Alteration of GIT flora</li>
                            <li>Hemolytic anemia with G6PDH deficiency</li>
                        </ol>

                        <h3 class="subsection-heading">e). MACROLIDE ANTIBIOTICS: Largely bacteriostatic</h3>
                        <p><strong>Mxn:</strong> binds to the 50s ribosomal subunit and interferes with protein synthesis.</p>
                        <p>E.g. Erythromycin, Clarithromycin, Azithromycin.</p>
                        <p><strong>Administration:</strong> - oral</p>
                        <p><strong>Absorption:</strong> good for clarithromycin; food interferes with azithromycin absorption</p>
                        <p><strong>Distribution:</strong> wide, crosses into placenta, but not into CSF, taken up by phagocytic cells. Azithromycin is deposited in tissues from where it is released slowly.</p>
                        <p><strong>Elimination:</strong> $t_{1/2}$ 1-5 hrs</p>
                        <ul>
                            <li>Erythromycin and Azithromycin: Biliary excretion (adjust dose in hepatic dysfunction)</li>
                            <li>Clarithromycin: liver metabolism and urinary excretion</li>
                        </ul>
                        <p><strong>S/E:</strong></p>
                        <ol>
                            <li>Cholestatic jaundice (reversible) erythromycin</li>
                            <li>GIT irritation</li>
                        </ol>
                        <p><strong>Drug interactions</strong> - Erythromycin and clarithromycin (but not azithromycin) inhibit Cytochrome P450 enzymes. They can increase plasma levels of: Warfarin, Carbamazepine, Theophylline, Oral digoxin, Methylpredisolone</p>
                        <h4 class="subsubsection-heading">Uses:</h4>
                        <p><strong>Erythromycin (mostly gm +ve bacteria)</strong></p>
                        <ul>
                            <li>DOC in community acquired pneumonia</li>
                            <li>Diphtheria</li>
                        </ul>
                        <p><strong>Azithromycin and Clarithromycin</strong></p>
                        <ul>
                            <li>DOC in chlamydial infections (cervicitis, urethritis, conjunctivitis)</li>
                            <li>Respiratory tract infections (caused by H. influenza, atypical pneumonia)</li>
                            <li>Soft tissue infections; Toxoplasmosis</li>
                            <li>Substitute in persons allergic to penicillins.</li>
                        </ul>
                        <p>Clarithromycin - H.pylori eradication.</p>

                        <h3 class="subsection-heading">f). LINCOSAMIDES E.g. Clindamycin, Lincomycin</h3>
                        <p><strong>Mxn:</strong> inhibits translocation process in protein synthesis.</p>
                        <p><strong>Administration</strong>- oral and parenteral</p>
                        <p><strong>Distribution:</strong> good penetration into all tissues (bone, abscesses, phagocytic cells) except brain,</p>
                        <p><strong>Elimination:</strong> liver metabolism, urinary and biliary excretion.</p>
                        <p><strong>S/E:</strong></p>
                        <ol>
                            <li>Pseudomembranous colitis (alteration of normal flora, C. difficile); stop treatment if diarrhea occurs and manage with metronidazole or vancomycin</li>
                            <li>Hypersensitivity</li>
                            <li>GIT irritation</li>
                            <li>Impaired liver function</li>
                        </ol>
                        <h4 class="subsubsection-heading">Uses:</h4>
                        <ul>
                            <li>Bacteroides fragilis infections abdominal sepsis, dental infections</li>
                            <li>Staphylococcal bone and joint infections</li>
                            <li>Non-sexually transmitted genital tract infections (combined with an aminoglycoside)</li>
                        </ul>
                    </div>
                </section>
                <!-- END: protein-synthesis-inhibitors -->

                <!-- START: nucleic-acid-synthesis-inhibitors -->
                <section id="nucleic-acid-synthesis-inhibitors" class="content-section" aria-labelledby="section-heading-nucleic-acid-inhibitors">
                    <h2 id="section-heading-nucleic-acid-inhibitors" class="section-heading">
                        <span class="heading-icon">üö´</span>
                        <span class="heading-text">3. Inhibitors of nucleic acid synthesis</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">a). FLOUROQUINOLONES - Bacteriocidal</h3>
                        <p><strong>Mxn:</strong> inhibits DNA gyrase (topoisomerase II) hence inhibition of DNA synthesis.</p>
                        <p><strong>Absorption</strong> - good per oral. $\text{Al}^{3+}, \text{Mg}^{2+}$, sucralfate and ferrous compounds interfere with absorption.</p>
                        <p><strong>Distribution:</strong> achieves effective conc. in a wide range of tissues esp. kidney, lung, prostate, phagocytes.</p>
                        <p><strong>Elimination:</strong> $t_{1/2}$ 2-10hrs. Undergoes hepatic metabolism followed by biliary and renal clearance</p>
                        <p><strong>S/E:</strong></p>
                        <ol>
                            <li>GIT irritation</li>
                            <li>Hypersensitivity reactions - skin rashes, photosensitivity, anaphylaxis</li>
                            <li>Arthropathy especially in children</li>
                            <li>CNS disturbance - especially with prior CNS pathology or use of theophyllilne or NSAIDS</li>
                        </ol>
                        <p><strong>Caution:</strong> don't drive or use machinery when on these drugs.</p>
                        <h4 class="subsubsection-heading">FLOUROQUINOLONES USES:</h4>
                        <ol>
                            <li>Urinary tract infections</li>
                            <li>GIT infections e.g. Salmonella typhi</li>
                            <li>Respiratory tract infections esp. P.aeruginosa</li>
                            <li>Gonorrhea, cervicitis, Septicemia</li>
                            <li>Osteomyelitis caused by gram-ve bacteria.</li>
                        </ol>
                        <p>E.g. Norfloxacin, Ciprofloxacin, Enoxacin, Ofloxacin, Lomefloxacine, Levofloxacin, Sparfloxacin, Clinafloxacin</p>
                        <p><strong>C/I:</strong></p>
                        <ul>
                            <li>Children under 18 years</li>
                            <li>Pregnancy and lactation.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: nucleic-acid-synthesis-inhibitors -->

                <!-- START: folic-acid-synthesis-inhibitors -->
                <section id="folic-acid-synthesis-inhibitors" class="content-section" aria-labelledby="section-heading-folic-acid-inhibitors">
                    <h2 id="section-heading-folic-acid-inhibitors" class="section-heading">
                        <span class="heading-icon">üìâ</span>
                        <span class="heading-text">4. Folic acid synthesis inhibitors</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">a). SULPHONAMIDES - Bacteriostatic, broad spectrum.</h3>
                        <p><strong>Mxn:</strong> Competitively inhibit dihydropteroate synthetase hence interfering with folic acid synthesis.</p>
                        <p><strong>Administation:</strong> oral and topical (eg. silversulphadiazine)</p>
                        <p><strong>Absorption:</strong> rapid for most (e.g. sulphamethoxazole), poor for sulphasalazine.</p>
                        <p><strong>Distribution:</strong> well into most tissues including CSF, placenta, inflammatory exudates</p>
                        <p><strong>Elimination:</strong> $t_{1/2}$ varies; Liver metabolism and renal clearance.</p>
                        <p><strong>S/E:</strong></p>
                        <ol>
                            <li>Hypersensitivity-inform of anaphylaxis, stevens-Johnson syndrome</li>
                            <li>Bone marrow depression (causes macrocytic anemia in high doses, avoid in pregnancy)</li>
                            <li>Crystalluria</li>
                            <li>CNS disturbance</li>
                            <li>Teratogenic (C/I in pregnancy)</li>
                        </ol>

                        <h4 class="subsubsection-heading">Sulphonamides examples:</h4>
                        <p><strong>Systemic drugs</strong></p>
                        <ol>
                            <li>Short acting -sulfisoxazole, sulfamethizole</li>
                            <li>Intermediate acting - sulphamethoxazole, sulfadiazine, sulfadimidine,</li>
                            <li>Long acting - sulfametopyrazine, sulfadoxine.</li>
                        </ol>
                        <p><strong>Non-systemic/local effect</strong></p>
                        <ol>
                            <li>Oral nonabsorbable (GIT effect)-sulfasalazine.</li>
                            <li>Topical - sulfacetamide (eye), Silver sulfadiazine (burns, wounds), Mefenide (burns, wounds)</li>
                        </ol>

                        <h4 class="subsubsection-heading">SULPHONAMIDES Uses (single drug):</h4>
                        <ol>
                            <li>Silversulphadiazine - (topical) prophylaxis and treatment of infected burns, pressure sores, skin ulcers</li>
                            <li>Inflammatory bowel disease - sulphasalazine or sulphapyridine + saliclylate</li>
                            <li>Some sexually transmitted infections chlamydia, trachoma, chancroid.</li>
                        </ol>

                        <h4 class="subsubsection-heading">Combined - (Trimethoprim + sulphamethoxazole = co-trimoxazole (septrin))</h4>
                        <p><strong>Uses of co-trimoxazole:</strong></p>
                        <ol>
                            <li>Pneumocystis jiroveci pneumonia</li>
                            <li>Toxoplasmosis</li>
                            <li>Norcadiosis (pneumonia and brain abscesses).</li>
                            <li>Chronic urinary tract infections.</li>
                            <li>Chronic bronchitis (2nd line drug)</li>
                            <li>Otitis media (2nd line drug)</li>
                            <li>Enteric bacteria</li>
                            <li>Respiratory infections.</li>
                        </ol>
                        <p><strong>Dosage (septrin):</strong> 960mg - 1.44g BD (P.O)</p>

                        <h3 class="subsection-heading">b). TRIMETHOPRIM: Bacteriostatic and broad spectrum.</h3>
                        <p><strong>Mxn:</strong> inhibitor of dihydrofolate reductase leading to the inhibition of DNA synthesis</p>
                        <p><strong>Administartion:</strong> oral</p>
                        <p><strong>Abs:</strong> rapid and complete</p>
                        <p><strong>Distribution:</strong> wide especially prostatic and vaginal fluids</p>
                        <p><strong>Elimination:</strong> $t_{1/2}$ 10hrs. Liver metabolism and urinary excretion</p>
                        <h4 class="subsubsection-heading">Uses: as a single drug</h4>
                        <ol>
                            <li>Urinary tract infections</li>
                            <li>Respiratory infections</li>
                        </ol>
                    </div>
                </section>
                <!-- END: folic-acid-synthesis-inhibitors -->

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="pharmacology-introduction.html" class="nav-button">
                        <span class="nav-icon">‚Üê</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 18%;"></div> <!-- Set percentage dynamically -->
                        </div>
                       <span class="progress-text">Lecture 2 of 11</span> <!-- Update text -->
                    </div>
                    <a href="pharmacology-chemotherapeutic-agents-antimycobacterials-antifungals-antivirals.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script> <!-- Basic JS for disabled links etc. -->
</body>
</html>